BRANDEE SALISBURY: Open Payments
NPI 1093461550 · CANYON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 12 payments from 8 companies in 2025. Trend: 2023 $161 · 2024 $179 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 1 | $38 |
| Astellas Pharma US Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: FARXIGA, RS-4i Plus with Intersperse, BREZTRI, Veozah, MOUNJARO, Wegovy, NURTEC ODT, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
